Filing Details
- Accession Number:
- 0001179110-17-010231
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-07 17:39:13
- Reporting Period:
- 2017-07-05
- Filing Date:
- 2017-07-07
- Accepted Time:
- 2017-07-07 17:39:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1034842 | Rigel Pharmaceuticals Inc | RIGL | Pharmaceutical Preparations (2834) | 943248524 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1419579 | Anne-Marie Duliege | Rigel Pharmaceuticals, Inc. 1180 Veterans Boulevard South San Francisco CA 94080 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-07-05 | 5,000 | $2.69 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 10, 2016.
- The Reporting Person purchased these shares on 6/30/17 under the Employee Stock Purchase Plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.75, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the range set forth in footnote three (3) of this Form 4.
Billionaire Hedge Funds
